X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29816) 29816
Publication (2457) 2457
Newsletter (689) 689
Newspaper Article (458) 458
Book Review (432) 432
Book Chapter (295) 295
Book / eBook (216) 216
Magazine Article (45) 45
Transcript (36) 36
Conference Proceeding (31) 31
Dissertation (26) 26
Trade Publication Article (25) 25
Data Set (8) 8
Web Resource (5) 5
Reference (2) 2
Report (2) 2
Government Document (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24882) 24882
male (15491) 15491
female (14112) 14112
index medicus (13729) 13729
transplantation (11983) 11983
middle aged (11494) 11494
adult (10437) 10437
liver transplantation - adverse effects (10015) 10015
liver (9212) 9212
surgery (8913) 8913
liver transplantation (6910) 6910
treatment outcome (6072) 6072
gastroenterology & hepatology (5837) 5837
risk factors (5505) 5505
aged (5441) 5441
immunology (4759) 4759
retrospective studies (4758) 4758
animals (3753) 3753
time factors (3715) 3715
adolescent (3609) 3609
child (3105) 3105
liver diseases (3104) 3104
health aspects (2753) 2753
liver-transplantation (2562) 2562
recipients (2478) 2478
care and treatment (2342) 2342
immunosuppressive agents - adverse effects (2266) 2266
research (2193) 2193
liver transplantation - methods (2187) 2187
disease (2166) 2166
follow-up studies (2164) 2164
child, preschool (2128) 2128
oncology (2044) 2044
immunosuppressive agents - therapeutic use (2019) 2019
mortality (2018) 2018
hepatitis (2002) 2002
therapy (1944) 1944
liver - pathology (1933) 1933
analysis (1922) 1922
prognosis (1913) 1913
young adult (1905) 1905
transplants & implants (1893) 1893
survival (1874) 1874
cirrhosis (1850) 1850
infant (1836) 1836
recurrence (1798) 1798
liver transplantation - mortality (1783) 1783
liver cirrhosis (1705) 1705
transplantation of organs, tissues, etc (1705) 1705
patients (1690) 1690
medicine (1671) 1671
cancer (1640) 1640
liver cancer (1626) 1626
living donors (1624) 1624
graft survival (1618) 1618
management (1571) 1571
risk-factors (1497) 1497
complications (1493) 1493
infection (1492) 1492
hepatocellular carcinoma (1487) 1487
immunosuppression (1456) 1456
pediatrics (1433) 1433
prospective studies (1421) 1421
kidney transplantation (1415) 1415
incidence (1405) 1405
risk assessment (1392) 1392
diagnosis (1390) 1390
children (1386) 1386
antiviral agents - therapeutic use (1359) 1359
survival rate (1359) 1359
pharmacology & pharmacy (1320) 1320
medicine, general & internal (1295) 1295
mice (1286) 1286
liver neoplasms - surgery (1276) 1276
rats (1248) 1248
medical research (1230) 1230
hematology (1229) 1229
research article (1202) 1202
biopsy (1169) 1169
complications and side effects (1166) 1166
liver neoplasms - pathology (1164) 1164
kidney transplantation - adverse effects (1154) 1154
hepatitis c (1150) 1150
gastroenterology and hepatology (1113) 1113
infections (1091) 1091
organ transplant recipients (1077) 1077
tacrolimus (1073) 1073
medicine & public health (1070) 1070
liver transplantation - immunology (1061) 1061
studies (1059) 1059
hepatology (1047) 1047
risk (1040) 1040
survival analysis (1025) 1025
drug therapy, combination (1021) 1021
abridged index medicus (1001) 1001
drug therapy (998) 998
infectious diseases (997) 997
postoperative complications (992) 992
article (990) 990
liver - metabolism (975) 975
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (163) 163
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Online Resources - Online (5) 5
St. Michael's Hospital - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Scarborough Hospital - General (3) 3
UofT at Mississauga - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Church Stacks (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Humber River Regional Hospital - Pharmacy (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Microtexts (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Toronto East General Hospital - Online (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30265) 30265
Spanish (285) 285
French (274) 274
Chinese (230) 230
German (210) 210
Japanese (70) 70
Italian (42) 42
Russian (41) 41
Hungarian (32) 32
Polish (28) 28
Portuguese (24) 24
Czech (19) 19
Korean (15) 15
Croatian (12) 12
Danish (12) 12
Dutch (11) 11
Swedish (7) 7
Turkish (6) 6
Hebrew (5) 5
Bulgarian (4) 4
Icelandic (4) 4
Romanian (4) 4
Finnish (3) 3
Norwegian (3) 3
Arabic (2) 2
Ukrainian (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Transplantation, ISSN 0041-1337, 10/2005, Volume 80, Issue 2, pp. S254 - S264
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 100 - 107.e1
Background & Aims Patients with detectable hepatitis C virus (HCV) RNA at the time of liver transplantation universally experience recurrent HCV infection.... 
Gastroenterology and Hepatology | Liver Transplantation | HCV Recurrence | Direct-Acting Antiviral Agents | Hepatitis C Virus | ALPHA-2A | CELLS | HEPATITIS-C INFECTION | ANTIVIRAL THERAPY | FUTURE | KINETICS | TOLERABILITY | CIRRHOSIS | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | PHASE-2 TRIAL | Recurrence | Carcinoma, Hepatocellular - mortality | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Middle Aged | Liver Cirrhosis - mortality | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Liver Neoplasms - mortality | Viral Load | Time Factors | Female | Hepatitis C - complications | Waiting Lists | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Europe | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Liver Transplantation - mortality | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Hepatitis C - mortality | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Aged | Sofosbuvir | Medical research | Relapse | RNA | Liver | Transplantation | Biological response modifiers | Ribavirin | Infection control | Diseases | Prevention | Medicine, Experimental | Hepatitis C virus | Hepatitis C | Health aspects
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 108 - 117
Background & Aims Interferon alfa–based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated,... 
Gastroenterology and Hepatology | Antiviral Agent | Clinical Trial | DAA | NS5B Polymerase Inhibitor | PLUS RIBAVIRIN | ANTIVIRAL THERAPY | EFFICACY | HCV GENOTYPE 1 | MULTICENTER EXPERIENCE | COMBINATION | RECIPIENTS | PEGYLATED INTERFERON | GRAFT-SURVIVAL | GASTROENTEROLOGY & HEPATOLOGY | DRUG-DRUG INTERACTIONS | Recurrence | Prospective Studies | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Viral Load | Time Factors | Ribavirin - pharmacokinetics | Female | Hepatitis C - complications | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Spain | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Virus diseases | Relapse | Liver | Transplantation | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Immunosuppressive agents | Ribavirin | Diseases
Journal Article
Nature, ISSN 0028-0836, 05/2018, Volume 557, Issue 7703, pp. 50 - 56
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2013, Volume 132, Issue 6, pp. 1429 - 1438
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article